Thus, the possibility to induce tumour cell death by incapacitating critical nodes of the oncogenic network provides a strong rationale for targeting the ErbB2/3 oncogenic unit and the downstream signalling in ErbB2-addicted tumours. This evidence concerns the gene ERBB2 and neoplasm.